T-cell responses to survivin in cancer patients undergoing radiation therapy. - Wikidata - awgldk - TriplyDB

T-cell responses to survivin in cancer patients undergoing radiation therapy.

T-cell responses to survivin in cancer patients undergoing radiation therapy.

http://www.wikidata.org/entity/Q37357113

about

Radiotherapy combination opportunities leveraging immunity for the next oncology practice Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy Combining radiotherapy and cancer immunotherapy: a paradigm shift Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols.Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer.Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.Radiation enhances regulatory T cell representation.TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity Maximizing tumor immunity with fractionated radiation.Chemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patient In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer.Current clinical trials testing combinations of immunotherapy and radiation.Combining radiation and immunotherapy for synergistic antitumor therapy.Cytokines in radiobiological responses: a review.Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF.Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.Systemic effects of local radiotherapy.Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinoma A Century of Radiation Therapy and Adaptive Immunity The confluence of stereotactic ablative radiotherapy and tumor immunology.Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.Opportunities and challenges of radiotherapy for treating cancer.In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment A perspective on the impact of radiation therapy on the immune rheostat.Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.Emerging immunotherapy for the treatment of esophageal cancer.PD-1 Restrains Radiotherapy-Induced Abscopal Effect.Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells DNA Damage and Repair Biomarkers of Immunotherapy Response.Intratumoral injection of interleukin-2 augments the local and abscopal effects of radiotherapy in murine rectal cancer.Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy.Regulatory T cells in radiotherapeutic responses.The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy.Local irradiation of murine melanoma affects the development of tumour-specific immunity.

P2860

Q26738443-6BF24B17-FBEF-40C6-A955-9D8AC930C371 Q27001216-4D232BF9-A789-46CC-BA27-0AC5AF888BFE Q27021428-4E54F930-38A8-4D04-8AE5-095A96EB318D Q30360210-619664E7-7ED2-4428-9D75-2E346AB6D47F Q33627023-9A5FF7A5-A150-4715-BAA8-7F568E6EB49B Q33816412-AA682BB4-A576-455C-9325-A9CF38ADF0C3 Q33834316-47434334-03D8-4DC2-AFD5-FA90118DDB4A Q33952083-0D1FEA60-E8B8-4D65-9A77-588EC8673DAC Q34989668-97F45C32-D95D-4A4F-AFB5-8FE1FD83803B Q35053414-FCAE7C2C-1773-4A84-A63A-2B5E74DD73FD Q35908369-35352792-2F25-4F7C-9D8F-B03C3167FC7C Q35916615-A579B8CE-D2D2-4029-9DAB-0253F27E28F1 Q36093045-A5442D23-49AC-440B-A5B2-6EEE14A64773 Q36210670-A67516B3-7799-40CB-846E-5C2F58E0EDBF Q36268306-C9CFA90F-796A-475A-895D-99E449FD386E Q36326598-ED588512-CDDB-47FB-BE26-9F0DB9667E8E Q37045283-0D383ADC-9877-4201-A1F0-BA9E62DB4340 Q37118895-9908857A-A843-4097-A533-EEBC0EDA25ED Q37322905-8611010E-F0FC-4569-8286-A8600A14A7E6 Q37351567-12D34C31-9269-4764-996F-7AB10E6FF221 Q37539309-94B5168C-7C54-4A89-8306-C16504E26F72 Q37632272-A205FDF5-C0CF-46FF-A610-F4787FD3BA3A Q37747153-7DDAF38A-043D-43AC-9142-82D5B259D3AE Q37967688-662125E8-A126-49EA-9475-8CA20330D1D0 Q38073096-D143891D-6103-4534-B6B6-7E932E4D65BE Q38217593-5DF90515-93E9-4E4B-BC75-8AF7D75672A4 Q38539957-DA1A66BA-697E-4BB2-AAD4-53466FFBC33E Q38543250-5436A055-8487-418D-ABAB-3052A0C982BA Q38679488-B4ABF549-DA68-483F-B8CF-AB80E2D9CF04 Q38760078-1A110B8C-8545-4B0D-BBD0-9CBE1338F649 Q38763851-555D3B52-A2DB-4D5B-9318-8FB8E1ACD0FB Q38907646-48F9EECB-9984-4C22-B1A2-E59FD3318E1E Q39292669-77C604B1-6D01-4772-A2E4-AF2665F85460 Q39384263-F0DBE1A3-538A-411D-B236-15D445B8069C Q39569395-3A938E96-8FAA-467D-A3D3-761C9459B49A Q41487973-6BA0DA24-B30B-4BCB-803B-3537CC0C599D Q42097323-62D57A45-F252-4AEC-BA8A-E3236521C785 Q42115384-C9101E3D-61EE-494C-93A1-E6B3DEB92713 Q42161730-A5DF5EFE-FA44-4AC6-883F-8DE4D120CDBE Q46022196-109EF68A-029A-459D-8274-8D7DB4BF134B

P2860

T-cell responses to survivin in cancer patients undergoing radiation therapy.

http://www.wikidata.org/entity/Q37357113

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

T-cell responses to survivin in cancer patients undergoing radiation therapy.

@en

T-cell responses to survivin in cancer patients undergoing radiation therapy.

@nl

type

label

T-cell responses to survivin in cancer patients undergoing radiation therapy.

@en

T-cell responses to survivin in cancer patients undergoing radiation therapy.

@nl

prefLabel

T-cell responses to survivin in cancer patients undergoing radiation therapy.

@en

T-cell responses to survivin in cancer patients undergoing radiation therapy.

@nl

P1433

Q37357113-2D4F240D-A48E-4A75-8B68-E0DDEEA616F6

P1476

Q37357113-DB3494B4-D995-4CA8-A0EA-96C14C198674

P2093

Q37357113-0E5FAD3C-2475-41DB-8498-91CEA875EFC6

Q37357113-1D6DFB15-83A3-4EB1-B9DF-BC71881471D2

Q37357113-331CB049-5A3D-41F6-BABF-533A65C32553

Q37357113-5142DF2A-9234-4742-B905-ECF7B3EF21A1

Q37357113-5D412F97-A740-4163-817B-B9E43AA4CB33

Q37357113-B4B4D95E-9B90-4388-9C13-2E543A913711

Q37357113-CF409AD1-1584-496D-897D-93356FE00E2B

Q37357113-EF207CD7-C27B-4ED9-9F09-21D758DB0303

Q37357113-F5EC164C-F08F-4363-93C1-0B6E8D43BC0C

P2860

Q37357113-01F67A1D-A8AD-4972-9094-72D9B87CFF18

Q37357113-04432501-9F9C-4756-8019-EBAF7BF9A262

Q37357113-13AB7D2E-0534-44B9-B8C6-CB59897E6B13

Q37357113-1C3790FB-202D-4423-921A-3696F729A227

Q37357113-2791F244-F7A6-4EA5-B169-342D6A172BD4

Q37357113-2A1AE667-5C40-463D-863F-173EC458BB2C

Q37357113-2F5E2E6B-1A5C-4C7E-B9E4-929050B91B97

Q37357113-30F21E2E-7ABE-4080-A1AE-7EE6F9B9BC4E

Q37357113-3662EA66-73D9-4A18-B184-F0BBDB400A47

Q37357113-463BDBCE-EC36-4E5F-A602-72C53981328E

P304

Q37357113-A2A2F677-099D-4F7F-B9EF-494661063163

P31

Q37357113-57D65486-C570-4A3E-8CF6-0446F326FDB3

P356

Q37357113-19FE14FD-3E1B-452B-909F-0609F82927D7

P407

Q37357113-37D9F0FC-AC24-488B-BCE1-C8237CCA5B0E

P433

Q37357113-6B851D4C-7F72-41AC-B0C4-3B3A67D0DA22

P478

Q37357113-BC2F0E1E-85A7-44AD-97FA-A4002FAFB032

P577

Q37357113-130BA734-4A1B-4389-B49B-4083F4494D55

P698

Q37357113-BEC46188-51F6-4150-AC11-5A9418E2BE2C

P921

Q37357113-9F42209E-EB7D-413C-8E66-D5011AEF0985

Q37357113-CB197507-7953-4F11-A165-957ACE417F10

P932

Q37357113-833131EF-0EB7-49D1-BCC1-0870690B7506

P356

1078-0432.CCR-07-4462

P1433

Clinical Cancer Research

P1476

T-cell responses to survivin in cancer patients undergoing radiation therapy.

@en

P2093

Annelies Debucquoy

http://www.w3.org/2001/XMLSchema#string

Antoni Ribas

http://www.w3.org/2001/XMLSchema#string

Begonya Comin-Anduix

http://www.w3.org/2001/XMLSchema#string

Dörthe Schaue

http://www.w3.org/2001/XMLSchema#string

James W Sayre

http://www.w3.org/2001/XMLSchema#string

Karin Haustermans

http://www.w3.org/2001/XMLSchema#string

Lee Goodglick

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

William H McBride

http://www.w3.org/2001/XMLSchema#string

P2860

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

Survivin as a target for new anticancer interventions

Separating the anti-apoptotic and mitotic roles of survivin

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.

Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer.

Type 1 T regulatory cells.

P304

4883-4890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-4462

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18676762

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2748652

http://www.w3.org/2001/XMLSchema#string